Steven Bryant
Net worth: 29 710 $ as of 2024-04-29
Profile
Steven R.
Bryant worked as an Executive Vice President-Sales & Marketing at Angiotech Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, he worked as a Vice President-Sales & Marketing at Surgical Specialties Corp.
He was also the President of International Biomedical Research Alliance.
Earlier in his career, he worked as a Principal at Chiron Vision Corp.
and IntraOptics.
Mr. Bryant received his undergraduate degree from Marshall University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
STELLA-JONES INC.
0.00% | 2024-03-13 | 507 ( 0.00% ) | 29 710 $ | 2024-04-29 |
Former positions of Steven Bryant
| Companies | Position | End |
|---|---|---|
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Sales & Marketing | 2013-03-21 |
International Biomedical Research Alliance
 International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | President | - |
| IntraOptics | Corporate Officer/Principal | - |
| Chiron Vision Corp. | Corporate Officer/Principal | - |
Surgical Specialties Corp.
 Surgical Specialties Corp. Medical SpecialtiesHealth Technology Surgical Specialties Corp. manufactures medical products. It specializes in designing and manufacturing of surgical knives and wound closure products. The firm offers suture needles, sutures, microsurgical cutting instruments, eye garters, and ophthalmic cannulas. The company is headquartered in Westwood, MA. | Sales & Marketing | - |
Training of Steven Bryant
| Marshall University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Surgical Specialties Corp.
Surgical Specialties Corp. Medical SpecialtiesHealth Technology Surgical Specialties Corp. manufactures medical products. It specializes in designing and manufacturing of surgical knives and wound closure products. The firm offers suture needles, sutures, microsurgical cutting instruments, eye garters, and ophthalmic cannulas. The company is headquartered in Westwood, MA. | Health Technology |
| Chiron Vision Corp. | |
| IntraOptics | |
International Biomedical Research Alliance
International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | Commercial Services |
- Stock Market
- Insiders
- Steven Bryant
